Cargando…

Colony Stimulating Factor 1 Receptor in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is an aggressive heterogeneous blood cancer derived from hematopoietic stem cells. Tumor-stromal interactions in AML are of importance for disease development and therapy resistance, and bone marrow stroma seem like an attractive therapeutic target. Of particular interes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sletta, Kristine Yttersian, Castells, Oriol, Gjertsen, Bjørn Tore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027480/ https://www.ncbi.nlm.nih.gov/pubmed/33842370 http://dx.doi.org/10.3389/fonc.2021.654817

Ejemplares similares

Granulocyte Colony-Stimulating Factor Receptor Mutations in Myeloid Malignancy
por: Liongue, Clifford, et al.
Publicado: (2014)

Colony-stimulating Factor 3 Receptor Mutated Chronic Neutrophilic Leukemia: A Rare Case Report
por: Thapa, Bicky, et al.
Publicado: (2018)

Drug Repurposing for the Treatment of Acute Myeloid Leukemia
por: Andresen, Vibeke, et al.
Publicado: (2017)

Intensive chemotherapy for acute myeloid leukemia differentially affects circulating T(C)1, T(H)1, T(H)17 and T(REG )cells
por: Ersvaer, Elisabeth, et al.
Publicado: (2010)

Case report: Identification of acute promyelocytic leukemia during osimertinib resistance followed by granulocyte colony-stimulating factor and pembrolizumab
por: Tian, Huohuan, et al.
Publicado: (2023)

Role of Granulocyte-Macrophage Colony-Stimulating Factor in Acute Myeloid Leukemia/Myelodysplastic Syndromes
por: Kassem, Neemat M., et al.
Publicado: (2017)

Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents
por: Fredly, Hanne, et al.
Publicado: (2013)

THBS1 Is a Novel Serum Prognostic Factors of Acute Myeloid Leukemia
por: Zhu, Lidan, et al.
Publicado: (2020)

Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling
por: Mercatelli, Daniele, et al.
Publicado: (2020)

Modulation of phospho-proteins by interferon-alpha and valproic acid in acute myeloid leukemia
por: Forthun, Rakel Brendsdal, et al.
Publicado: (2019)

Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells
por: Wergeland, Line, et al.
Publicado: (2007)

A review of granulocyte colony-stimulating factor receptor signaling and regulation with implications for cancer
por: Park, Sungjin David, et al.
Publicado: (2022)

Murine Models of Acute Myeloid Leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2022)

The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
por: Fredly, Hanne, et al.
Publicado: (2013)

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)

IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
por: Cerchione, Claudio, et al.
Publicado: (2021)

Anti-Tumor Effects of BDH1 in Acute Myeloid Leukemia
por: Han, Fei, et al.
Publicado: (2021)

Wilms Tumor 1 Mutations Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia
por: Wang, Yin, et al.
Publicado: (2021)

Radiolabeled Monoclonal Antibody Against Colony-Stimulating Factor 1 Receptor Specifically Distributes to the Spleen and Liver in Immunocompetent Mice
por: Waaijer, Stijn J. H., et al.
Publicado: (2021)

Genomics of Acute Myeloid Leukemia: The Next Generation
por: Riva, Laura, et al.
Publicado: (2012)

Clinical Implications of Inflammation in Acute Myeloid Leukemia
por: Récher, Christian
Publicado: (2021)

Editorial: Precision medicine for acute myeloid leukemia
por: Marconi, Giovanni, et al.
Publicado: (2023)

Corrigendum: Murine models of acute myeloid leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2023)

Runt-Related Transcription Factor 3 Promotes Acute Myeloid Leukemia Progression
por: Zhang, Wenwen, et al.
Publicado: (2021)

Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia
por: Øyan, Anne Margrete, et al.
Publicado: (2009)

Methylation of SPRED1: A New Target in Acute Myeloid Leukemia
por: Su, Nan, et al.
Publicado: (2022)

Epigenetic Silencing of Immune-Checkpoint Receptors in Bone Marrow- Infiltrating T Cells in Acute Myeloid Leukemia
por: Radpour, Ramin, et al.
Publicado: (2021)

Preleukemia and Leukemia-Initiating Cell Activity in inv(16) Acute Myeloid Leukemia
por: Pulikkan, John Anto, et al.
Publicado: (2018)

Harnessing the Metabolic Vulnerabilities of Leukemia Stem Cells to Eradicate Acute Myeloid Leukemia
por: Kumar, Bijender
Publicado: (2021)

Acute Myeloid Leukemia as a Model for Cancer Therapy
por: Ravandi, Farhad
Publicado: (2012)

Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia
por: Tasian, Sarah K., et al.
Publicado: (2014)

Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
por: Wei, Yunxiong, et al.
Publicado: (2020)

Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2019)

Immunotherapy in Acute Myeloid Leukemia: Where We Stand
por: Isidori, Alessandro, et al.
Publicado: (2021)

Vitamin C Deficiency in Patients With Acute Myeloid Leukemia
por: Ottone, Tiziana, et al.
Publicado: (2022)

Research progress on molecular biomarkers of acute myeloid leukemia
por: Yin, Pei-Yuan, et al.
Publicado: (2023)

Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis
por: Tettero, Jesse M., et al.
Publicado: (2022)

SPRED1 Is Downregulated and a Prognostic Biomarker in Adult Acute Myeloid Leukemia
por: Zhang, Rui, et al.
Publicado: (2020)

Targeting the GFI1/1B—CoREST Complex in Acute Myeloid Leukemia
por: van Bergen, Maaike G. J. M., et al.
Publicado: (2019)

Oxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenografts
por: Yttersian Sletta, Kristine, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qu092ju4o9j6lbsirviuntl94q